Evidence map›Paper›PMID 32957171›Full record

ReviewZhongguo fei ai za zhi = Chinese journal of lung cancer2020

[Progress in Survival Prognosis of Segmentectomy for 
Early-stage Non-small Cell Lung Cancer].

Sunyin Rao, Lianhua Ye, Xin Cui, Qinling Sun, Run Cao, Shouyong Xiao, Jichen Yang, Wei Wang, Guangqiang Zhao, Yunchao Huang

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. A novel nomogram incorporating LASSO and Cox regression analyses for predicting survival in early-stage non-small cell lung cancer patients following sublobectomy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Sunyin RaoDepartment of Thoracic Surgery, the Third Affiliated Hospital of Kunming Medical University, Kunming 650105, China.
Lianhua YeDepartment of Thoracic Surgery, the Third Affiliated Hospital of Kunming Medical University, Kunming 650105, China.
Xin CuiDepartment of Thoracic Surgery, the Third Affiliated Hospital of Kunming Medical University, Kunming 650105, China.
Qinling SunDepartment of Thoracic Surgery, the Third Affiliated Hospital of Kunming Medical University, Kunming 650105, China.
Run CaoDepartment of Thoracic Surgery, the Third Affiliated Hospital of Kunming Medical University, Kunming 650105, China.
Shouyong XiaoDepartment of Thoracic Surgery, the Third Affiliated Hospital of Kunming Medical University, Kunming 650105, China.
Jichen YangDepartment of Thoracic Surgery, the Third Affiliated Hospital of Kunming Medical University, Kunming 650105, China.
Wei WangDepartment of Thoracic Surgery, the Third Affiliated Hospital of Kunming Medical University, Kunming 650105, China.
Guangqiang ZhaoDepartment of Thoracic Surgery, the Third Affiliated Hospital of Kunming Medical University, Kunming 650105, China.
Yunchao HuangDepartment of Thoracic Surgery, the Third Affiliated Hospital of Kunming Medical University, Kunming 650105, China.
Kunming Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surgery is currently the most appropriate treatment for early-stage non-small cell lung cancer (NSCLC). Increasing unilateral or bilateral multiple primary lung cancer being found, segmentectomy has attracted wide attention for its unique advantages in the treatment for such tumors. Ground glass opacity dominant early-stage NSCLC is associated with a good prognosis and can be cured by segmentectomy, however, the treatment of solid-dominant NSCLC remains controversial owing to the invasive nature. With the in-depth study on the lymph node metastasis pathway, radiological characteristics and molecular biology of NSCLC, a large part of solid nodules with certain characteristics can also be cured by segmentectomy. This paper reviews the research status and progress about the indication of segmentectomy.
.

Indexed as

PneumonectomyCarcinoma, Non-Small-Cell LungHumansLung NeoplasmsNeoplasm StagingPrognosisSurvival AnalysisIndicationLung neoplasmsSegmentectomySolid nodulesSurvival prognosis

Identifiers

PMID32957171
PMCPMC7519961
OpenAlexW3087437590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.